LadRx Corp (LADXD)

[Massen]

While I did remember the share price for the Ocata buyout, I couldn't recall the total price. Looked it up to find out that it was $379 million. This was for a company (while all of us shareholders thought it was worth lots more) that had not even begun to start recruiting for Phase 2. I can't conceive that Cytrx is intrinsically worth less, so IMO the floor for a buyout (should one occur) would have to be approximately $400 million. At present shares outstanding this would equate to $2.40/share. Back in my fantasy days I would never have even considered such a "lowball" offer. Now I would be hard pressed not to accept it.